Anti-colonic Cancer Effect in Vitro of MUC1 Specific CTLs Induced by MUC1 Core Peptide Tandem Repeats Gene-Modified Dendritic Cells Via Lentiviral Transduction

WANG Bin,ZHU Yi,ZHANG Jing-jing,XU Ze-kuan
DOI: https://doi.org/10.3760/cma.j.issn.1001-9030.2012.02.014
2012-01-01
Abstract:Objective To investigate the ability of MUC1 core peptide tandem repeats (TR)gene-modified dendritic cells (DC) (via lentiviral transduction) to elicit antigen-specific antitumor immunoresponse to colonic cancer in vitro.Methods DCs were induced from CD14 positive human peripheral blood mononuclear cells and infected with the lentiviral expression vector pLV-MUC1 which contains human MUC1 TR gene.The infected DCs were co-cultured with autologous T cells at a DC/T ratio of 1∶10 for 21 days to induce cytotoxic T lymphocyte(CTL).CTL and targeted cancer cells were then co-cultured at the E/T ratios of 5 ∶ 1,10 ∶ 1 and 20 ∶ 1.The cytotoxic activities of induced CTL to targeted cancer cells were analyzed with lactate dehydrogenase (LDH) releasing assay.Elispot assay was used to detect the interferon (IFN)-γ release.The pLV-GFP infected DC and non-infected DC groups were used as control.Results Expression of green fluorescence in pLV-MUC1 infected DCs was observed under a fluorescence microscope and the infection efficiency determined by flow cytometry was about 32%.The cytotoxicity of CTL induced by pLV-MUC1 infected DCs to HCT-116 ( MUC1 +,HLA-A2 + ) cancer cells was [ ( 12.74 ± 1.91 ) %,(23.14 ± 2.97) %,(35.38 ± 3.15 ) % at E/T ratios of 5 ∶ 1,10 ∶ 1,20 ∶ 1 ] significantly higher than control groups (P <0.01 ).The IFN-γsecretion of CTL induced by pLV-MUC1 infected DCs was also higher than control groups (P < 0.01 ).Conclusion The MUC1 core peptide tandem repeats gene modified DC (via lentiviral transduction) could effectively induce antigen-specific antitumor immunoresponse to colonic cancer in vitro.
What problem does this paper attempt to address?